- Report
- November 2023
- 30 Pages
Global
From €3090EUR$3,250USD£2,650GBP
- Report
- August 2023
- 161 Pages
Global
From €2377EUR$2,500USD£2,039GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,631GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,631GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,631GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,631GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,631GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,631GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,631GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1901EUR$2,000USD£1,631GBP
- Report
- January 2024
- 120 Pages
Global
From €7558EUR$7,950USD£6,483GBP
- Report
- April 2024
- 183 Pages
Global
From €4658EUR$4,900USD£3,996GBP
- Report
- January 2024
- 188 Pages
Global
From €4658EUR$4,900USD£3,996GBP
- Report
- January 2024
- 182 Pages
Global
From €4658EUR$4,900USD£3,996GBP
- Report
- January 2024
- 175 Pages
Global
From €4658EUR$4,900USD£3,996GBP
- Report
- November 2023
- 175 Pages
Global
From €4658EUR$4,900USD£3,996GBP
- Report
- October 2023
- 190 Pages
Global
From €4658EUR$4,900USD£3,996GBP
- Report
- October 2023
- 188 Pages
Global
From €4658EUR$4,900USD£3,996GBP
- Report
- October 2023
- 189 Pages
Global
From €4658EUR$4,900USD£3,996GBP
- Report
- July 2023
- 117 Pages
Global
From €4278EUR$4,500USD£3,669GBP
The Targeted Therapies market within the context of Genomics is focused on the development of treatments that target specific genetic mutations or pathways. These therapies are designed to be more effective and have fewer side effects than traditional treatments. Genomics has enabled the development of personalized treatments that are tailored to the individual patient's genetic makeup. This has allowed for the development of drugs that target specific mutations or pathways, leading to more effective treatments.
The Targeted Therapies market is a rapidly growing field, with many companies investing in research and development. Companies such as Gilead Sciences, Novartis, and AstraZeneca are leading the way in the development of targeted therapies. Other companies such as Merck, Pfizer, and Roche are also investing in the development of targeted therapies. Show Less Read more